vs
Side-by-side financial comparison of Crexendo, Inc. (CXDO) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Crexendo, Inc. is the larger business by last-quarter revenue ($18.1M vs $9.2M, roughly 2.0× Foghorn Therapeutics Inc.). Crexendo, Inc. runs the higher net margin — 6.7% vs -234.3%, a 241.0% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 11.2%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 12.4%).
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
CXDO vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.1M | $9.2M |
| Net Profit | $1.2M | $-21.7M |
| Gross Margin | — | — |
| Operating Margin | 6.3% | -258.2% |
| Net Margin | 6.7% | -234.3% |
| Revenue YoY | 11.2% | 223.8% |
| Net Profit YoY | 140.2% | -11.1% |
| EPS (diluted) | $0.03 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.1M | $9.2M | ||
| Q3 25 | $17.5M | $8.2M | ||
| Q2 25 | $16.6M | $7.6M | ||
| Q1 25 | $16.1M | $6.0M | ||
| Q4 24 | $16.2M | $2.9M | ||
| Q3 24 | $15.6M | $7.8M | ||
| Q2 24 | $14.7M | $6.9M | ||
| Q1 24 | $14.3M | $5.0M |
| Q4 25 | $1.2M | $-21.7M | ||
| Q3 25 | $1.4M | $-15.8M | ||
| Q2 25 | $1.2M | $-17.9M | ||
| Q1 25 | $1.2M | $-18.8M | ||
| Q4 24 | $507.0K | $-19.5M | ||
| Q3 24 | $148.0K | $-19.1M | ||
| Q2 24 | $588.0K | $-23.0M | ||
| Q1 24 | $434.0K | $-25.0M |
| Q4 25 | 6.3% | -258.2% | ||
| Q3 25 | 7.5% | -226.9% | ||
| Q2 25 | 6.7% | -279.2% | ||
| Q1 25 | 7.2% | -385.0% | ||
| Q4 24 | 3.9% | -840.5% | ||
| Q3 24 | 0.9% | -305.5% | ||
| Q2 24 | 3.9% | -386.6% | ||
| Q1 24 | 3.4% | -558.3% |
| Q4 25 | 6.7% | -234.3% | ||
| Q3 25 | 8.3% | -194.4% | ||
| Q2 25 | 7.4% | -237.3% | ||
| Q1 25 | 7.3% | -316.4% | ||
| Q4 24 | 3.1% | -682.9% | ||
| Q3 24 | 0.9% | -244.9% | ||
| Q2 24 | 4.0% | -333.6% | ||
| Q1 24 | 3.0% | -495.4% |
| Q4 25 | $0.03 | $-0.35 | ||
| Q3 25 | $0.05 | $-0.25 | ||
| Q2 25 | $0.04 | $-0.28 | ||
| Q1 25 | $0.04 | $-0.30 | ||
| Q4 24 | $0.03 | $-0.23 | ||
| Q3 24 | $0.00 | $-0.31 | ||
| Q2 24 | $0.02 | $-0.45 | ||
| Q1 24 | $0.01 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $80.9M |
| Total DebtLower is stronger | $114.0K | — |
| Stockholders' EquityBook value | $63.8M | $-108.5M |
| Total Assets | $77.7M | $198.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $80.9M | ||
| Q3 25 | — | $89.3M | ||
| Q2 25 | — | $72.6M | ||
| Q1 25 | — | $61.0M | ||
| Q4 24 | — | $55.5M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $138.9M | ||
| Q1 24 | — | $79.3M |
| Q4 25 | $114.0K | — | ||
| Q3 25 | $236.0K | — | ||
| Q2 25 | $356.0K | — | ||
| Q1 25 | $475.0K | — | ||
| Q4 24 | $592.0K | — | ||
| Q3 24 | $709.0K | — | ||
| Q2 24 | $823.0K | — | ||
| Q1 24 | $937.0K | — |
| Q4 25 | $63.8M | $-108.5M | ||
| Q3 25 | $61.3M | $-89.7M | ||
| Q2 25 | $58.3M | $-76.7M | ||
| Q1 25 | $55.2M | $-61.7M | ||
| Q4 24 | $51.4M | $-45.5M | ||
| Q3 24 | $49.5M | $-28.3M | ||
| Q2 24 | $48.2M | $-14.3M | ||
| Q1 24 | $46.8M | $-97.5M |
| Q4 25 | $77.7M | $198.1M | ||
| Q3 25 | $76.0M | $205.0M | ||
| Q2 25 | $71.4M | $226.2M | ||
| Q1 25 | $67.4M | $258.7M | ||
| Q4 24 | $64.9M | $284.0M | ||
| Q3 24 | $62.3M | $308.4M | ||
| Q2 24 | $59.6M | $328.6M | ||
| Q1 24 | $57.5M | $255.0M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-22.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-22.3M | ||
| Q3 25 | $4.4M | $-18.9M | ||
| Q2 25 | $1.3M | $-21.0M | ||
| Q1 25 | $1.2M | $-24.0M | ||
| Q4 24 | $2.2M | $-24.5M | ||
| Q3 24 | $1.6M | $-21.0M | ||
| Q2 24 | $2.7M | $-25.5M | ||
| Q1 24 | $-166.0K | $-29.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.3M | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | $2.1M | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.7% | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | 13.2% | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.3% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 0.2% | 16.8% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.0% | 2.0% |
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.05× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | 10.95× | — | ||
| Q2 24 | 4.51× | — | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
FHTX
Segment breakdown not available.
